Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer

doi:10.3748/wjg.v23.i10.1891

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9387)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

538

WORD

208

HTML

5010

Tables (1-4)

219

Sum=5975

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1141

Download

2271

Sum=3412

Mar 14, 2017 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 14, 2017; 23(10): 1891-1898
Published online Mar 14, 2017. doi: 10.3748/wjg.v23.i10.1891

Table 3 Correlations between the EORTC QLQ-CR29 and the QLQ-C30

	EORTC-QLQ-C30
	QOL	PF	RF	EF	CF	SF	FA	NV	PA	DY	SL	AP	CO	DI	FI
CR29 scales
Urinary frequency	0.004	-0.071	-0.111^a	-0.083	-0.163^b	-0.159^b	0.107^a	-0.130^a	-0.033	-0.046	0.061	0.023	-0.131^a	-0.022	0.063
Blood and mucus in stool	-0.412^b	-0.320^b	-0.074	-0.091	-0.166^b	0.077	0.296^b	0.383^b	0.451^b	0.166^b	0.190^b	0.120^a	0.321^b	0.526^b	-0.141^a
Stool frequency	-0.322^b	-0.236^b	-0.075	-0.132^a	-0.115^a	-0.026	0.268^b	0.340^b	0.349^b	0.212^b	0.188^b	0.120^a	0.247^b	0.492^b	-0.113^a
Body image	0.254^b	0.179^b	-0.052	0.051	0.100	-0.172^b	-0.303^b	-0.485^b	-0.363^b	-0.251^b	-0.185^b	-0.279^b	-0.240^b	-0.224^b	0.132^a
CR29 single items
Urinary incontinence	0.084	0.040	0.237^b	0.203^b	-0.071	0.171^b	-0.038	0.270^b	0.125^a	0.311^b	0.080	0.040	0.135^a	0.139^b	-0.291^b
Dysuria	0.032	0.101	0.223^b	0.210^b	-0.185^b	0.288^b	0.053	0.330^b	0.272^b	0.296^b	0.133^a	0.003	0.279^b	0.158^b	-0.294^b
Abdominal pain	-0.357^b	-0.399^b	-0.149^b	-0.086	-0.245^b	0.097	0.411^b	0.342^b	0.648^b	0.321^b	0.307^b	0.241^b	0.375^b	0.381^b	-0.118^a
Buttock pain	-0.114^a	-0.105	0.129^a	0.056	-0.138^a	0.271^b	0.131^a	0.487^b	0.343^b	0.224^b	0.178^b	0.139^b	0.278^b	0.160^b	-0.273^b
Bloating	-0.261^b	-0.233^b	-0.277^b	-0.302^b	-0.129^a	-0.206^b	0.213^b	0.080	0.240^b	0.130^a	0.221^b	0.183^b	0.207^b	0.252^b	0.125^a
Dry mouth	-0.117^a	-0.074	0.181^b	0.120^a	-0.104	0.216^b	0.152^b	0.321^b	0.262^b	0.358^b	0.134^a	0.110^a	0.218^b	0.122^a	-0.163^b
Hair loss	-0.112^a	-0.085	0.167^b	0.037	-0.131^a	0.222^b	0.184^b	0.486^b	0.286^b	0.276^b	0.108^a	0.127^a	0.232^b	0.155^b	-0.200^b
Taste	-0.218^b	-0.238^b	-0.214^b	-0.278^b	-0.222^b	-0.107^a	0.266^b	0.137^a	0.102	0.088	0.294^b	0.459^b	0.013	0.163^b	0.083
Anxiety	-0.233^b	-0.147^b	-0.425^b	-0.547^b	-0.033	-0.412^b	0.150^b	-0.272^b	-0.103	-0.095	0.011	0.134^a	-0.089	0.066	0.449^b
Weight	-0.217^b	-0.266^b	-0.346^b	-0.371^b	-0.175^b	-0.244^b	0.287^b	0.042	0.103	0.026	0.202^b	0.287^b	0.005	0.184^b	0.306^b
Flatulence	-0.057	-0.094	0.170^b	0.039	-0.115^a	0.159^b	0.092	0.433^b	0.206^b	0.180^b	0.106^a	0.180^b	0.200^b	0.236^b	-0.166^b
Fecal incontinence	-0.017	-0.032	0.275^b	0.218^b	-0.129^a	0.320^b	0.049	0.447^b	0.284^b	0.252^b	0.163^b	0.055	0.229^b	0.257^b	-0.350^b
Sore skin	-0.052	-0.132^a	0.208^b	0.170^b	-0.094	0.296^b	0.081	0.497^b	0.205^b	0.130^a	0.160^b	0.123^a	0.106^a	0.194^b	-0.271^b
Embarrassment	-0.049	-0.041	0.200^b	0.085	-0.019	0.209^b	0.036	0.317^b	0.167^b	-0.006	0.027	0.059	0.070	0.088	-0.209^b
Stoma care problems	-0.184	0.210	0.224	-0.254	0.044	0.064	-0.025	0.019	-0.033	-0.265	-0.059	0.007	-0.161	0.073	0.175
Sexual interest (men)	-0.108	-0.177^a	-0.051	0.041	-0.276^b	-0.184^b	0.142^a	-0.089	0.051	0.119	0.112	0.004	-0.010	0.039	0.092
Impotence	-0.026	-0.102	0.189^b	0.177^a	-0.212^b	0.243^b	0.105	0.242^b	0.082	0.155^a	0.175^a	0.157^a	0.069	0.093	-0.256^b
Sexual interest (women)	-0.319^b	-0.213^a	-0.092	0.030	-0.386^b	-0.006	0.091	-0.099	0.044	0.194	0.270^b	0.056	0.176	-0.010	0.215^a
Dyspareunia	0.026	0.003	0.213^b	0.322^b	-0.129	0.258^b	-0.094	0.423^b	0.185	0.227^a	0.005	0.090	0.312^b	0.117	-0.193

^aP < 0.05,

^bP < 0.01, EORTC QLQ-CR29 vs the QLQ-C30. QOL: Quality of life; PF: Physical functioning; RF: Role functioning; EF: Emotional functioning; CF: Cognitive functioning; SF: Social functioning; FA: Fatigue; NV: Nausea/vomiting; PA: Pain; DY: Dyspnea; SL: Insomnia; AP: Appetite loss; CO: Constipation; DI: Diarrhea; FI: Financial problems.

Citation: Lin JB, Zhang L, Wu DW, Xi ZH, Wang XJ, Lin YS, Fujiwara W, Tian JR, Wang M, Peng P, Guo A, Yang Z, Luo L, Jiang LY, Li QQ, Zhang XY, Zhang YF, Xu HW, Yang B, Li XL, Lei YX. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer. World J Gastroenterol 2017; 23(10): 1891-1898
URL: https://www.wjgnet.com/1007-9327/full/v23/i10/1891.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i10.1891